2023 Form 5500 filing — Mirati Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240517111159NAL0052287952001) for Mirati Therapeutics, Inc. 401(K) Plan, reported by Mirati Therapeutics, Inc. under EIN 46-2693615 and plan number 001. It reports 659 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240517111159NAL0052287952001
Filing year
2023
Form type
2
Plan sponsor
Mirati Therapeutics, Inc.
EIN
46-2693615
Plan number
001
Location
San Diego, CA
Participants
659
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$58,080,074
Total liabilities (EOY)
$0
Net assets (EOY)
$58,080,074
Employer contributions
$7,457,379
Participant contributions
$11,347,303
Total income / additions
$30,538,049
Benefits paid
$3,961,043
Administrative expenses
$77,082
Total expenses
$4,043,714
Net increase / (decrease)
$26,494,335
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
First Light Retirement LLCADVISOR$38,899not reported in the loaded dataset
First Light Retirement LLCINVESTMENT ADV/ADVISOR$38,395not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER$38,183$0
Fidelity Investments InstitutionalRECORDKEEPER$23,458$0
Jgd & Associates LlpACCOUNTANT/AUDITOR$18,033not reported in the loaded dataset

Related Form 5500 pages